FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Machele Donat

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

BCG Vaccine

Physiology

Disease Progression

Co-author Network

Publications

TOP 3
Jonathan L Silberstein; Bernard H Bochner; Guido Dalbagni; S Machele Donat; Tullika Garg; Harry W Herr; William T Lowrance; Alexandra C Maschino; Stephen A Poon; Jaspreet S Sandhu
Urinary diversion practice patterns among certifying American urologists.
Sam S Chang; Philipp Dahm; Colin P N Dinney; S Machele Donat; Felix Y Feng; John L Gore; Donna Hansel; Yair Lotan; Peter H O'Donnell; Dipen J Parekh; David B Solit; Matthew I Milowsky
12th Annual meeting of the Society of Urologic Oncology (SUO) bladder cancer sessions I and II summary report.
Jennifer M Taylor; Melanie Bernstein; Andrew Feifer; Harry W Herr; Alexandra C Maschino; Caroline J Savage; S Machele Donat
Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Machele Donat (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jonathan L Silberstein; Bernard H Bochner; Guido Dalbagni; S Machele Donat; Tullika Garg; Harry W Herr; William T Lowrance; Alexandra C Maschino; Stephen A Poon; Jaspreet S Sandhu
Urinary diversion practice patterns among certifying American urologists.
The Journal of urology 2013;189(3):1042-7.
2012: Sam S Chang; Philipp Dahm; Colin P N Dinney; S Machele Donat; Felix Y Feng; John L Gore; Donna Hansel; Yair Lotan; Peter H O'Donnell; Dipen J Parekh; David B Solit; Matthew I Milowsky
12th Annual meeting of the Society of Urologic Oncology (SUO) bladder cancer sessions I and II summary report.
Urologic oncology 2012;30(6):944-7.
2012: Jennifer M Taylor; Melanie Bernstein; Andrew Feifer; Harry W Herr; Alexandra C Maschino; Caroline J Savage; S Machele Donat
Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer.
BJU international 2012;109(6):855-9.
2011: Harry W Herr; Guido Dalbagni; S Machele Donat
Bacillus Calmette-Guérin without maintenance therapy for high-risk non-muscle-invasive bladder cancer.
European urology 2011;60(1):32-6.
2011: Guido Dalbagni; Bernard H Bochner; Angel Cronin; Harry W Herr; S Machele Donat
A plea for a uniform surveillance schedule after radical cystectomy.
The Journal of urology 2011;185(6):2091-6.
2011: S Machele Donat
Re: Khan et al.: analysis of early complications of robotic-assisted radical cystectomy using a standardized reporting system (Urology 2011;77:357-362).
Urology 2011;77(4):1016-7; author reply 1017.
2011: S Machele Donat
Editorial comment. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder.
Urology 2011;77(3):666-7; author reply 667.
2011: Harry W Herr; S Machele Donat
Reduced bladder tumour recurrence rate associated with narrow-band imaging surveillance cystoscopy.
BJU international 2011;107(3):396-8.
2010: S Machele Donat
Assessing urological complications of radiation therapy and surgical approaches for repair.
The Journal of urology 2010;184(6):2233-4.
2010: Guido Dalbagni; Matthew Kaag; Angel Cronin; Kinjal Vora; Bernard H Bochner; S Machele Donat; Harry W Herr
Variability of treatment selection among surgeons for patients with cT1 urothelial carcinoma.
BJU international 2010;106(10):1502-7.
2010: Daher C Chade; Shahrokh F Shariat; Ari Adamy; Bernard H Bochner; S Machele Donat; Harry W Herr; Guido Dalbagni
Clinical outcome of primary versus secondary bladder carcinoma in situ.
The Journal of urology 2010;184(2):464-9.
2010: Daher C Chade; Shahrokh F Shariat; Guilherme Godoy; Caroline J Savage; Angel M Cronin; Bernard H Bochner; S Machele Donat; Harry W Herr; Guido Dalbagni
Clinical outcomes of primary bladder carcinoma in situ in a contemporary series.
The Journal of urology 2010;184(1):74-80.
2010: Harry W Herr; S Machele Donat; Guido Dalbagni; Jennifer Taylor
Narrow-band imaging cystoscopy to evaluate bladder tumours--individual surgeon variability.
BJU international 2010;106(1):53-5.
2010: S Machele Donat; Timothy Siegrist; Angel Cronin; Caroline Savage; Matthew I Milowsky; Harry W Herr
Radical cystectomy in octogenarians--does morbidity outweigh the potential survival benefits?
The Journal of urology 2010;183(6):2171-7.
2010: S Machele Donat
Editorial comment.
Urology 2010;75(5):1090; author reply 1090-1.
2010: William T Lowrance; David S Yee; Caroline Savage; Angel M Cronin; Matthew F O'Brien; S Machele Donat; Andrew J Vickers; Paul Russo
Complications after radical and partial nephrectomy as a function of age.
The Journal of urology 2010;183(5):1725-30.
2010: David S Yee; Shahrokh F Shariat; William T Lowrance; Joseph R Sterbis; Kinjal C Vora; Bernard H Bochner; S Machele Donat; Harry W Herr; Guido Dalbagni; Jaspreet S Sandhu
Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer.
The Journal of urology 2010;183(5):1751-6.
2010: S Machele Donat
Editorial comment.
The Journal of urology 2010;183(3):934.
2010: Timothy Siegrist; Caroline Savage; Ahmad Shabsigh; Angel Cronin; S Machele Donat
Analysis of gender differences in early perioperative complications following radical cystectomy at a tertiary cancer center using a standardized reporting methodology.
Urologic oncology 2010;28(1):112-7.
2010: William T Lowrance; R Houston Thompson; David S Yee; Matthew Kaag; S Machele Donat; Paul Russo
Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies.
BJU international 2010;105(1):16-20.
2009: Guido Dalbagni; Kinjal C Vora; Matthew Kaag; Angel Cronin; Bernard H Bochner; S Machele Donat; Harry W Herr
Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer.
European urology 2009;56(6):903-10.
2009: David J Gallagher; Matthew I Milowsky; Alexia Iasonos; Fernando C Maluf; Paul Russo; Guido Dalbagni; S Machele Donat; Mary G Boyle; Junting Zheng; Jamie Riches; Dean F Bajorin
Sequential adjuvant chemotherapy after surgical resection of high-risk urothelial carcinoma.
Cancer 2009;115(22):5193-201.
2009: S Machele Donat
Integrating perioperative chemotherapy into the treatment of muscle-invasive bladder cancer: strategy versus reality.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(1):40-7.
2009: Ahmad Shabsigh; Ruslan Korets; Kinjal C Vora; Christine M Brooks; Angel M Cronin; Caroline Savage; Ganesh V Raj; Bernard H Bochner; Guido Dalbagni; Harry W Herr; S Machele Donat
Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology.
European urology 2009;55(1):164-74.
2009: S Machele Donat; Ahmad Shabsigh; Caroline Savage; Angel M Cronin; Bernard H Bochner; Guido Dalbagni; Harry W Herr; Matthew I Milowsky
Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience.
European urology 2009;55(1):177-85.
2008: Harry W Herr; S Machele Donat
Quality control in transurethral resection of bladder tumours.
BJU international 2008;102(9 Pt B):1242-6.
2008: William Alago; Constantinos T Sofocleous; Anne M Covey; Raymond H Thornton; S Machele Donat; Lynn A Brody; George I Getrajdman; Karen T Brown
Placement of transileal conduit retrograde nephroureteral stents in patients with ureteral obstruction after cystectomy: technique and outcome.
AJR. American journal of roentgenology 2008;191(5):1536-9.
2008: Atreya Dash; Joseph A Pettus; Harry W Herr; Bernard H Bochner; Guido Dalbagni; S Machele Donat; Paul Russo; Mary G Boyle; Matthew I Milowsky; Dean F Bajorin
A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience.
Cancer 2008;113(9):2471-7.
2008: Harry W Herr; S Machele Donat
A comparison of white-light cystoscopy and narrow-band imaging cystoscopy to detect bladder tumour recurrences.
BJU international 2008;102(9):1111-4.
2008: S Machele Donat
Argument against frozen section analysis of distal ureters in transitional cell bladder cancer.
Nature clinical practice. Urology 2008;5(10):538-9.
2008: Theresa Koppie; Angel M Serio; Andrew J Vickers; Kinjal C Vora; Guido Dalbagni; S Machele Donat; Harry W Herr; Bernard H Bochner
Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer.
Cancer 2008;112(11):2384-92.
2008: Joseph A Pettus; Hikmat Al-Ahmadie; Daniel A Barocas; Theresa Koppie; Harry W Herr; S Machele Donat; Guido Dalbagni; Victor E Reuter; Semra Olgac; Bernard H Bochner
Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy.
European urology 2008;53(2):370-5.
2008: William Tran; Angel M Serio; Ganesh V Raj; Guido Dalbagni; Andrew J Vickers; Bernard H Bochner; Harry W Herr; S Machele Donat
Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance.
The Journal of urology 2008;179(1):96-100.
2007: Zohar A Dotan; Kathryn Kavanagh; Ofer Yossepowitch; Matt Kaag; Semra Olgac; S Machele Donat; Harry W Herr
Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
The Journal of urology 2007;178(6):2308-12; discussion 2313.
2007: Jennifer H Yang; S Machele Donat
Elisabeth Pauline Pickett (1918-): opening the door for women in urological oncology.
The Journal of urology 2007;178(5):1875-7.
2007: Harry W Herr; S Machele Donat; Victor E Reuter
Management of low grade papillary bladder tumors.
The Journal of urology 2007;178(4 Pt 1):1201-5; discussion 1205.
2007: Dipen J Parekh; S Machele Donat
Urinary diversion: options, patient selection, and outcomes.
Seminars in oncology 2007;34(2):98-109.
2007: Ganesh V Raj; Harry W Herr; Angel M Serio; S Machele Donat; Bernard H Bochner; Andrew J Vickers; Guido Dalbagni
Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer.
The Journal of urology 2007;177(4):1283-6; discussion 1286.
2007: Ofer Yossepowitch; Harry W Herr; S Machele Donat
Use of urinary biomarkers for bladder cancer surveillance: patient perspectives.
The Journal of urology 2007;177(4):1277-82; discussion 1282.
2007: Matthew D Galsky; Alexia Iasonos; Svetlana Mironov; Joseph Scattergood; S Machele Donat; Bernard H Bochner; Harry W Herr; Paul Russo; Mary G Boyle; Dean F Bajorin
Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.
Urology 2007;69(2):255-9.
2007: S Machele Donat
Standards for surgical complication reporting in urologic oncology: time for a change.
Urology 2007;69(2):221-5.
2007: Harry W Herr; Zohar A Dotan; S Machele Donat; Dean F Bajorin
Defining optimal therapy for muscle invasive bladder cancer.
The Journal of urology 2007;177(2):437-43.
2007: Cora N Sternberg; S Machele Donat; Joaquim Bellmunt; Randall E Millikan; Walter Stadler; P H M De Mulder; Amir Sherif; Hans von der Maase; Taiji Tsukamoto; Mark S Soloway
Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer.
Urology 2007;69(1 Suppl):62-79.
2007: Harry W Herr; S Machele Donat; Guido Dalbagni
Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?
The Journal of urology 2007;177(1):75-9; discussion 79.
2006: Joseph A Pettus; Scott E Eggener; Ahmad Shabsigh; Brent V Yanke; Mark E Snyder; Angel M Serio; Andrew J Vickers; Paul Russo; S Machele Donat
Perioperative clinical thromboembolic events after radical or partial nephrectomy.
Urology 2006;68(5):988-92.
2006: Ganesh V Raj; Bernard H Bochner; Angel M Serio; Andrew J Vickers; S Machele Donat; Harry W Herr; Oscar Lin; Guido Dalbagni
Natural history of positive urinary cytology after radical cystectomy.
The Journal of urology 2006;176(5):2000-5; discussion 2005.
2006: S Machele Donat
Staged based directed surveillance of invasive bladder cancer following radical cystectomy: valuable and effective?
World journal of urology 2006;24(5):557-64.
2006: Ganesh V Raj; Raanan Tal; Andrew J Vickers; Bernard H Bochner; Angel M Serio; S Machele Donat; Harry W Herr; Semra Olgac; Guido Dalbagni
Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancer.
Cancer 2006;107(9):2167-72.
2006: Ofer Yossepowitch; Scott E Eggener; Bernard H Bochner; S Machele Donat; Harry W Herr; Guido Dalbagni
Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients.
The Journal of urology 2006;176(2):482-5.
2006: Yoshiya Yamada; Sudershan Bhatia; Marco Zaider; Gilad Cohen; S Machele Donat; James A Eastham; Farhang Rabbani; Karen Schupak; James Lee; Boris Mueller; Michael J Zelefsky
Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer.
Brachytherapy 2006;5(3):157-64.
2006: Ganesh V Raj; Alexia Iasonos; Harry W Herr; S Machele Donat
Formulas calculating creatinine clearance are inadequate for determining eligibility for Cisplatin-based chemotherapy in bladder cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3095-100.
2006: Jaspreet S Sandhu; Andrew J Vickers; Bernard H Bochner; S Machele Donat; Harry W Herr; Guido Dalbagni
Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer.
BJU international 2006;98(1):59-62.
2006: Guido Dalbagni; Paul Russo; Bernard H Bochner; Leah Ben-Porat; Joel Sheinfeld; Pramod C Sogani; S Machele Donat; Harry W Herr; Dean F Bajorin
Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(18):2729-34.
2006: Ganesh V Raj; Bernard H Bochner; Andrew J Vickers; Ervin Teper; Oscar Lin; S Machele Donat; Harry W Herr; Guido Dalbagni
Association between urinary cytology and pathology for nontransitional cell malignancies of the urinary tract.
The Journal of urology 2006;175(6):2038-41; discussion 2041.
2006: Harry W Herr; S Machele Donat
A re-staging transurethral resection predicts early progression of superficial bladder cancer.
BJU international 2006;97(6):1194-8.
2006: S Machele Donat; Elan W Salzhauer; Nandita Mitra; Brent V Yanke; Mark E Snyder; Paul Russo
Impact of body mass index on survival of patients with surgically treated renal cell carcinoma.
The Journal of urology 2006;175(1):46-52.
2005: Jason Hafron; Nandita Mitra; Guido Dalbagni; Bernard H Bochner; Harry W Herr; S Machele Donat
Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer?
The Journal of urology 2005;173(5):1513-7.
2004: Michael Mullerad; Paul Russo; Dragan Golijanin; Hui-Ni Chen; Harold H Tsai; S Machele Donat; Bernard H Bochner; Harry W Herr; Joel Sheinfeld; Pramod C Sogani; Michael W Kattan; Guido Dalbagni
Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma.
The Journal of urology 2004;172(6 Pt 1):2177-81.
2004: Bernard H Bochner; Daniel Cho; Harry W Herr; S Machele Donat; Michael W Kattan; Guido Dalbagni
Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping.
The Journal of urology 2004;172(4 Pt 1):1286-90.
2004: Jeffrey M Holzbeierlein; Ernesto Lopez-Corona; Bernard H Bochner; Harry W Herr; S Machele Donat; Paul Russo; Guido Dalbagni; Pramod C Sogani
Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.
The Journal of urology 2004;172(3):878-81.
2004: Tomas Kirchhoff; Noah D Kauff; Nandita Mitra; Khedoudja Nafa; Helen Huang; Crystal Palmer; Tony Gulati; Eve A Wadsworth; S Machele Donat; Mark Robson; Nathan Ellis; Kenneth Offit
BRCA mutations and risk of prostate cancer in Ashkenazi Jews.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):2918-21.
2004: Badrinath R Konety; James A Eastham; Victor E Reuter; Peter T Scardino; S Machele Donat; Guido Dalbagni; Paul Russo; Harry W Herr; Lawrence H Schwartz; Philip W Kantoff; Howard I Scher; W Kevin Kelly
Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study.
The Journal of urology 2004;171(2 Pt 1):709-13.
2004: S Machele Donat; Amanda North; Guido Dalbagni; Harry W Herr
Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5 cm.
The Journal of urology 2004;171(2 Pt 1):636-9.
2003: Padmanee Sharma; Sacha Gnjatic; Achim A Jungbluth; Barbara Williamson; Harry W Herr; Elisabeth Stockert; Guido Dalbagni; S Machele Donat; Victor E Reuter; Darren Santiago; Yao-Tseng Chen; Dean F Bajorin; Lloyd J Old
Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer.
Cancer immunity 2003;3():19.
2003: S Machele Donat
Evaluation and follow-up strategies for superficial bladder cancer.
The Urologic clinics of North America 2003;30(4):765-76.
2003: S Machele Donat; Sharon Bayuga; Harry W Herr; Marianne Berwick
Fluid intake and the risk of tumor recurrence in patients with superficial bladder cancer.
The Journal of urology 2003;170(5):1777-80.
2003: Paul Sweeney; Randall Millikan; S Machele Donat; Christopher G Wood; Arlene Siefker Radtke; Curtis A Pettaway; H Barton Grossman; Colin P N Dinney; David A Swanson; Louis L Pisters
Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?
The Journal of urology 2003;169(6):2113-7.
2003: Ofer Yossepowitch; Guido Dalbagni; Dragan Golijanin; S Machele Donat; Bernard H Bochner; Harry W Herr; William R Fair; Paul Russo
Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence.
The Journal of urology 2003;169(1):177-81.
2002: Harry W Herr; S Machele Donat; Guido Dalbagni
Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder.
The Journal of urology 2002;168(3):978-80.
2002: Guido Dalbagni; Paul Russo; Joel Sheinfeld; Madhu Mazumdar; William Tong; Farhang Rabbani; S Machele Donat; Harry W Herr; Pramod C Sogani; Dominique dePalma; Dean F Bajorin
Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3193-8.
2002: John W Davis; Louis L Pisters; Michael J Doviak; S Machele Donat
Early nasogastric tube removal combined with metoclopramide after postchemotherapy retroperitoneal lymph node dissection for metastatic testicular nonseminomatous germ cell tumor.
Urology 2002;59(4):579-83.
2002: Harry W Herr; Bernard H Bochner; Guido Dalbagni; S Machele Donat; Victor E Reuter; Dean F Bajorin
Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.
The Journal of urology 2002;167(3):1295-8.
2001: Guido Dalbagni; S Machele Donat; Pascal Eschwège; Harry W Herr; Michael J Zelefsky
Results of high dose rate brachytherapy, anterior pelvic exenteration and external beam radiotherapy for carcinoma of the female urethra.
The Journal of urology 2001;166(5):1759-61.
2001: Clair L Shadbolt; Fergus V Coakley; A Qayyum; S Machele Donat
MRI of vaginal leiomyomas.
Journal of computer assisted tomography 2001;25(3):355-7.
2001: S Machele Donat; David C Wei; M S McGuire; Harry W Herr
The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer.
The Journal of urology 2001;165(5):1580-4.
2001: S Machele Donat; Elizabeth M Genega; Harry W Herr; Victor E Reuter
Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance.
The Journal of urology 2001;165(4):1117-20.
2001: Harry W Herr; S Machele Donat; Dean F Bajorin
Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer.
The Journal of urology 2001;165(3):811-4.
2001: Harry W Herr; S Machele Donat
Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy.
The Journal of urology 2001;165(1):62-4; discussion 64.
2000: DA Corral; Datla G K Varma; Edward F Jackson; Robert J Amato; S Machele Donat; Louis L Pisters
Magnetic resonance imaging and magnetic resonance angiography before postchemotherapy retroperitoneal lymph node dissection.
Urology 2000;55(2):262-6.
1999: S Machele Donat
Peri-operative care in patients treated for testicular cancer.
Seminars in surgical oncology 1999;17(4):282-8.
1999: S Machele Donat; Joel W Slaton; Louis L Pisters; David A Swanson
Early nasogastric tube removal combined with metoclopramide after radical cystectomy and urinary diversion.
The Journal of urology 1999;162(5):1599-602.
1999: Harry W Herr; S Machele Donat
Prostatic tumor relapse in patients with superficial bladder tumors: 15-year outcome.
The Journal of urology 1999;161(6):1854-7.
1998: S Machele Donat; DA Levy
Bleomycin associated pulmonary toxicity: is perioperative oxygen restriction necessary?
The Journal of urology 1998;160(4):1347-52.
1996: S Machele Donat; Harry W Herr; Dean F Bajorin; W R Fair; Pramod C Sogani; Paul Russo; Joel Sheinfeld; I Scher
Methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and cystectomy for unresectable bladder cancer.
The Journal of urology 1996;156(2 Pt 1):368-71.
1996: S Machele Donat; Paul Russo
Ureteral decompression in advanced nonurologic malignancies.
Annals of surgical oncology 1996;3(4):393-9.
1996: R. Duane Duane Cespedes; Edward J McGuire; S Machele Donat; R J Babaian
Bladder preservation and continent urinary diversion in T3b transitional cell carcinoma of the bladder.
Seminars in urologic oncology 1996;14(2):103-11.
1995: S Machele Donat; CT Powell; R S Israeli; W R Fair; Warren D W Heston
Reversal by transferrin of growth-inhibitory effect of suramin on hormone-refractory human prostate cancer cells.
Journal of the National Cancer Institute 1995;87(1):41-6.
1995: P C Brenner; Paul Russo; David P Wood Jr; M J Morse; S Machele Donat; W R Fair
Salvage radical prostatectomy in the management of locally recurrent prostate cancer after 125I implantation.
British journal of urology 1995;75(1):44-7.
1988: S Machele Donat; P E Donat
Intrathoracic kidney: a case report with a review of the world literature.
The Journal of urology 1988;140(1):131-3.